F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Chronic hepatitis c

1	Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways 11/24/2023 6:10:12 AM \| Browse: 71 \| Download: 135
2	Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report 10/25/2023 8:49:11 AM \| Browse: 119 \| Download: 212
3	Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients 6/9/2022 7:17:55 AM \| Browse: 273 \| Download: 1079
4	Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil 1/21/2022 8:16:14 AM \| Browse: 376 \| Download: 630
5	Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study 11/10/2021 7:13:09 AM \| Browse: 569 \| Download: 688
6	Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis 5/14/2021 10:27:31 AM \| Browse: 494 \| Download: 745
7	Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study 5/10/2021 7:46:10 AM \| Browse: 315 \| Download: 772
8	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 337 \| Download: 651
9	Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients 2/25/2021 3:45:30 PM \| Browse: 523 \| Download: 1102
10	Management of hepatitis C in children and adolescents during COVID-19 pandemic 8/25/2020 9:16:00 AM \| Browse: 617 \| Download: 1112
11	Liver-related effects of chronic hepatitis C antiviral treatment 6/14/2020 1:45:26 PM \| Browse: 786 \| Download: 1236
12	Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus 4/23/2020 10:34:55 AM \| Browse: 538 \| Download: 1400
13	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 1000 \| Download: 1203
14	Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy 8/26/2019 2:56:47 AM \| Browse: 680 \| Download: 1679
15	High prevalence of occult hepatitis C infection in predialysis patients 1/27/2019 7:04:05 AM \| Browse: 743 \| Download: 1170
16	Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus 10/12/2018 5:32:21 AM \| Browse: 665 \| Download: 912
17	Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection 3/26/2018 8:48:04 AM \| Browse: 1141 \| Download: 2050
18	Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis 1/26/2018 8:09:36 AM \| Browse: 952 \| Download: 1312
19	Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1 12/27/2017 10:31:19 AM \| Browse: 987 \| Download: 1644
20	Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment 7/7/2017 11:41:16 AM \| Browse: 938 \| Download: 1532
21	Interferon related pericarditis: Review 6/26/2017 12:49:43 AM \| Browse: 980 \| Download: 1196
22	Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting 6/14/2017 9:25:57 AM \| Browse: 977 \| Download: 1772
23	Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C 6/7/2017 7:22:42 AM \| Browse: 1640 \| Download: 2988
24	Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review 5/17/2017 6:29:40 AM \| Browse: 1270 \| Download: 1716
25	Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b 4/6/2017 6:30:00 PM \| Browse: 1109 \| Download: 1490
26	Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C 2/27/2017 8:50:00 AM \| Browse: 1057 \| Download: 1320
27	Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data 2/17/2017 8:32:00 AM \| Browse: 1064 \| Download: 1458
28	Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C 11/26/2016 6:56:00 PM \| Browse: 1021 \| Download: 2013
29	Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature 11/6/2016 3:43:00 PM \| Browse: 873 \| Download: 1057
30	Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 10/14/2016 1:37:00 PM \| Browse: 1135 \| Download: 1125
31	Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C 9/30/2016 5:59:00 PM \| Browse: 1092 \| Download: 1894
32	Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication 9/4/2016 2:49:00 PM \| Browse: 1268 \| Download: 1616
33	Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles 7/29/2016 8:32:00 PM \| Browse: 981 \| Download: 1442
34	Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter? 4/19/2016 9:45:00 AM \| Browse: 1059 \| Download: 2227
35	Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1 3/23/2016 4:26:00 PM \| Browse: 1274 \| Download: 1885
36	Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage 1/20/2016 5:04:00 PM \| Browse: 1186 \| Download: 1248
37	Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver 12/10/2015 10:35:00 AM \| Browse: 1018 \| Download: 1264
38	Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching 12/4/2015 3:24:00 PM \| Browse: 1029 \| Download: 1909
39	Treatment of chronic hepatitis C in patients with HIV/HCV coinfection 12/2/2015 12:06:00 PM \| Browse: 467 \| Download: 825
40	Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C 11/18/2015 11:12:00 AM \| Browse: 968 \| Download: 989
41	Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C 11/18/2015 11:12:00 AM \| Browse: 984 \| Download: 1582
42	Era of direct acting antivirals in chronic hepatitis C: Who will benefit? 10/30/2015 11:57:00 AM \| Browse: 1402 \| Download: 1462
43	Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals 10/14/2015 12:06:00 PM \| Browse: 1096 \| Download: 1384
44	Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment 9/23/2015 12:28:00 PM \| Browse: 1673 \| Download: 1693
45	Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients 8/8/2015 3:25:00 PM \| Browse: 1024 \| Download: 1953
46	Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers 7/30/2015 11:19:00 AM \| Browse: 1184 \| Download: 1434
47	Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: a case report and systematic review of literature 6/29/2015 5:40:00 PM \| Browse: 879 \| Download: 1376
48	Impact of direct acting antiviral-based triple therapy on the serum alpha-fetoprotein level 4/30/2015 2:11:00 PM \| Browse: 974 \| Download: 1536
49	Management of hepatitis C infection before and after liver transplantation 4/30/2015 2:11:00 PM \| Browse: 997 \| Download: 1300
50	Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C 4/7/2015 6:08:00 PM \| Browse: 959 \| Download: 1391

Page 1 of 2 ( 74 items )
<<
1
2
>>

1	Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways 11/24/2023 6:10:12 AM \| Browse: 71 \| Download: 135
2	Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report 10/25/2023 8:49:11 AM \| Browse: 119 \| Download: 212
3	Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients 6/9/2022 7:17:55 AM \| Browse: 273 \| Download: 1079
4	Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil 1/21/2022 8:16:14 AM \| Browse: 376 \| Download: 630
5	Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study 11/10/2021 7:13:09 AM \| Browse: 569 \| Download: 688
6	Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis 5/14/2021 10:27:31 AM \| Browse: 494 \| Download: 745
7	Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study 5/10/2021 7:46:10 AM \| Browse: 315 \| Download: 772
8	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 337 \| Download: 651
9	Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients 2/25/2021 3:45:30 PM \| Browse: 523 \| Download: 1102
10	Management of hepatitis C in children and adolescents during COVID-19 pandemic 8/25/2020 9:16:00 AM \| Browse: 617 \| Download: 1112
11	Liver-related effects of chronic hepatitis C antiviral treatment 6/14/2020 1:45:26 PM \| Browse: 786 \| Download: 1236
12	Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus 4/23/2020 10:34:55 AM \| Browse: 538 \| Download: 1400
13	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 1000 \| Download: 1203
14	Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy 8/26/2019 2:56:47 AM \| Browse: 680 \| Download: 1679
15	High prevalence of occult hepatitis C infection in predialysis patients 1/27/2019 7:04:05 AM \| Browse: 743 \| Download: 1170
16	Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus 10/12/2018 5:32:21 AM \| Browse: 665 \| Download: 912
17	Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection 3/26/2018 8:48:04 AM \| Browse: 1141 \| Download: 2050
18	Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis 1/26/2018 8:09:36 AM \| Browse: 952 \| Download: 1312
19	Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1 12/27/2017 10:31:19 AM \| Browse: 987 \| Download: 1644
20	Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment 7/7/2017 11:41:16 AM \| Browse: 938 \| Download: 1532
21	Interferon related pericarditis: Review 6/26/2017 12:49:43 AM \| Browse: 980 \| Download: 1196
22	Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting 6/14/2017 9:25:57 AM \| Browse: 977 \| Download: 1772
23	Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C 6/7/2017 7:22:42 AM \| Browse: 1640 \| Download: 2988
24	Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review 5/17/2017 6:29:40 AM \| Browse: 1270 \| Download: 1716
25	Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b 4/6/2017 6:30:00 PM \| Browse: 1109 \| Download: 1490
26	Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C 2/27/2017 8:50:00 AM \| Browse: 1057 \| Download: 1320
27	Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data 2/17/2017 8:32:00 AM \| Browse: 1064 \| Download: 1458
28	Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C 11/26/2016 6:56:00 PM \| Browse: 1021 \| Download: 2013
29	Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature 11/6/2016 3:43:00 PM \| Browse: 873 \| Download: 1057
30	Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 10/14/2016 1:37:00 PM \| Browse: 1135 \| Download: 1125
31	Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C 9/30/2016 5:59:00 PM \| Browse: 1092 \| Download: 1894
32	Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication 9/4/2016 2:49:00 PM \| Browse: 1268 \| Download: 1616
33	Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles 7/29/2016 8:32:00 PM \| Browse: 981 \| Download: 1442
34	Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter? 4/19/2016 9:45:00 AM \| Browse: 1059 \| Download: 2227
35	Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1 3/23/2016 4:26:00 PM \| Browse: 1274 \| Download: 1885
36	Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage 1/20/2016 5:04:00 PM \| Browse: 1186 \| Download: 1248
37	Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver 12/10/2015 10:35:00 AM \| Browse: 1018 \| Download: 1264
38	Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching 12/4/2015 3:24:00 PM \| Browse: 1029 \| Download: 1909
39	Treatment of chronic hepatitis C in patients with HIV/HCV coinfection 12/2/2015 12:06:00 PM \| Browse: 467 \| Download: 825
40	Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C 11/18/2015 11:12:00 AM \| Browse: 968 \| Download: 989
41	Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C 11/18/2015 11:12:00 AM \| Browse: 984 \| Download: 1582
42	Era of direct acting antivirals in chronic hepatitis C: Who will benefit? 10/30/2015 11:57:00 AM \| Browse: 1402 \| Download: 1462
43	Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals 10/14/2015 12:06:00 PM \| Browse: 1096 \| Download: 1384
44	Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment 9/23/2015 12:28:00 PM \| Browse: 1673 \| Download: 1693
45	Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients 8/8/2015 3:25:00 PM \| Browse: 1024 \| Download: 1953
46	Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers 7/30/2015 11:19:00 AM \| Browse: 1184 \| Download: 1434
47	Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: a case report and systematic review of literature 6/29/2015 5:40:00 PM \| Browse: 879 \| Download: 1376
48	Impact of direct acting antiviral-based triple therapy on the serum alpha-fetoprotein level 4/30/2015 2:11:00 PM \| Browse: 974 \| Download: 1536
49	Management of hepatitis C infection before and after liver transplantation 4/30/2015 2:11:00 PM \| Browse: 997 \| Download: 1300
50	Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C 4/7/2015 6:08:00 PM \| Browse: 959 \| Download: 1391